论文部分内容阅读
目的:研究生殖道感染与非足月胎膜早破的相关性。方法:选择我院在2015年5月-2016年5月收治的50非足月胎膜早破孕妇为研究对象,与同一阶段在我院住院的50例正常孕妇进行对比。使非足月胎膜早破孕妇表示观察组,正常孕妇表示对照组。对两组孕妇的阴道、宫颈管的分泌物和念珠菌进行全面的检查和检测,之后将两组检测结果进行对比。结果:观察组孕妇的宫颈管分泌物解脲支原体检查、阴道分泌物细菌性阴道病检查明显比对照组要高,两组数据差异具有统计学意义(p<0.05),但是两组孕妇的念珠菌检测并没有太大的差别,所以两组数据差异没有统计学意义(p>0.05)。并且观察组产妇的新生儿并发症要比对照组高,两组数据差异具有统计学意义(p<0.05)。结论:生殖道感染与非足月胎膜早破具有密切的关系,非足月胎膜早破合并生殖道感染严重影响了孕妇和新生儿,所以孕妇要在妊娠前进行预防,在妊娠早期及中期对孕妇进行筛选,对不同的病因进行针对性的防治措施,以此降低非足月胎膜早破的发生几率。
Objective: To study the correlation between genital tract infection and premature rupture of membranes. Methods: 50 pregnant women with premature rupture of membranes in our hospital from May 2015 to May 2016 were selected as the study subjects, and compared with 50 normal pregnant women hospitalized in our hospital in the same stage. So that non-term premature rupture of membranes of pregnant women that the observation group, the normal pregnant women that the control group. The two groups of pregnant women’s vagina, cervical canal secretions and Candida conduct a comprehensive inspection and testing, after the two groups of test results were compared. Results: In the observation group, the cervix secretion of Ureaplasma urealyticum in pregnant women was significantly higher than that in the control group (P <0.05). However, there was no significant difference between the two groups There was not much difference in the detection of bacteria, so there was no significant difference between the two groups (p> 0.05). And the observation group maternal neonatal complications than the control group, the difference between the two groups was statistically significant (p <0.05). Conclusion: There is a close relationship between genital tract infection and premature rupture of membranes in premature pregnancy. Premature rupture of membrane and reproductive tract infection have a serious impact on pregnant women and newborns. Therefore, pregnant women should be prevented before pregnancy. In early pregnancy and Mid-term screening of pregnant women, for different causes of targeted prevention and treatment measures to reduce the incidence of non-full-term premature rupture of membranes.